PBM
Psyence Biomedical·NASDAQ
--
--(--)
--
--(--)
PBM Filings
Filing Date
Form Description
Form Type
2026-01-29
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-29 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-27
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-27 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-14
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-14 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-13 ·
Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2026-01-13
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-13 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2026-01-13
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2026-01-13 ·
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
2026-01-08
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2026-01-08 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-12-10
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-12-10 ·
Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
2025-11-21
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-21 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-20
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-20 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
